Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells

Songyot Anuchapreeda, Pranee Leechanachai, Melissa Smith-Phillips, Suresh V. Ambudkar, Porn ngarm Limtrakul

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

Multidrug resistance (MDR) is a phenomenon that is often associated with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux. It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity. In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10μM curcumin for up to 72hr was able to significantly lower Pgp expression in KB-V1 cells. Curcumin (1-10μM) decreased Pgp expression in a concentration-dependent manner and was also found to have the same effect on MDR1 mRNA levels. The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells. Curcumin increased Rh123 accumulation in a concentration-dependent manner (1-55μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells. Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123. In addition, curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concentration-dependent manner, demonstrating that curcumin interacts directly with the transporter. Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells. In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochemical curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.

Original languageEnglish (US)
Pages (from-to)573-582
Number of pages10
JournalBiochemical Pharmacology
Volume64
Issue number4
DOIs
StatePublished - Aug 15 2002
Externally publishedYes

Fingerprint

KB Cells
Curcumin
P-Glycoprotein
Modulation
Rhodamine 123
Cells
Pharmaceutical Preparations
Tumors
Neoplasms
Vinblastine
Prazosin
Polymerase chain reaction
Phytochemicals
Multiple Drug Resistance
Transcription
Cytotoxicity
Verapamil
Labeling
Reverse Transcription
Adenosine Triphosphatases

Keywords

  • ATP hydrolysis
  • Chemosensitizers
  • Curcumin
  • KB-V1 cells
  • Multidrug resistance
  • P-glycoprotein

ASJC Scopus subject areas

  • Pharmacology

Cite this

Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. / Anuchapreeda, Songyot; Leechanachai, Pranee; Smith-Phillips, Melissa; Ambudkar, Suresh V.; Limtrakul, Porn ngarm.

In: Biochemical Pharmacology, Vol. 64, No. 4, 15.08.2002, p. 573-582.

Research output: Contribution to journalArticle

Anuchapreeda, Songyot ; Leechanachai, Pranee ; Smith-Phillips, Melissa ; Ambudkar, Suresh V. ; Limtrakul, Porn ngarm. / Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. In: Biochemical Pharmacology. 2002 ; Vol. 64, No. 4. pp. 573-582.
@article{6b423665d823480992dfebd290fc46a3,
title = "Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells",
abstract = "Multidrug resistance (MDR) is a phenomenon that is often associated with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux. It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity. In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10μM curcumin for up to 72hr was able to significantly lower Pgp expression in KB-V1 cells. Curcumin (1-10μM) decreased Pgp expression in a concentration-dependent manner and was also found to have the same effect on MDR1 mRNA levels. The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells. Curcumin increased Rh123 accumulation in a concentration-dependent manner (1-55μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells. Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123. In addition, curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concentration-dependent manner, demonstrating that curcumin interacts directly with the transporter. Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells. In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochemical curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.",
keywords = "ATP hydrolysis, Chemosensitizers, Curcumin, KB-V1 cells, Multidrug resistance, P-glycoprotein",
author = "Songyot Anuchapreeda and Pranee Leechanachai and Melissa Smith-Phillips and Ambudkar, {Suresh V.} and Limtrakul, {Porn ngarm}",
year = "2002",
month = "8",
day = "15",
doi = "10.1016/S0006-2952(02)01224-8",
language = "English (US)",
volume = "64",
pages = "573--582",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells

AU - Anuchapreeda, Songyot

AU - Leechanachai, Pranee

AU - Smith-Phillips, Melissa

AU - Ambudkar, Suresh V.

AU - Limtrakul, Porn ngarm

PY - 2002/8/15

Y1 - 2002/8/15

N2 - Multidrug resistance (MDR) is a phenomenon that is often associated with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux. It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity. In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10μM curcumin for up to 72hr was able to significantly lower Pgp expression in KB-V1 cells. Curcumin (1-10μM) decreased Pgp expression in a concentration-dependent manner and was also found to have the same effect on MDR1 mRNA levels. The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells. Curcumin increased Rh123 accumulation in a concentration-dependent manner (1-55μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells. Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123. In addition, curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concentration-dependent manner, demonstrating that curcumin interacts directly with the transporter. Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells. In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochemical curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.

AB - Multidrug resistance (MDR) is a phenomenon that is often associated with decreased intracellular drug accumulation in the tumor cells of a patient, resulting from enhanced drug efflux. It is often related to the overexpression of P-glycoprotein (Pgp) on the surface of tumor cells, thereby reducing drug cytotoxicity. In this study, curcumin was tested for its potential ability to modulate the expression and function of Pgp in the multidrug-resistant human cervical carcinoma cell line KB-V1. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) showed that treatment with 1, 5, and 10μM curcumin for up to 72hr was able to significantly lower Pgp expression in KB-V1 cells. Curcumin (1-10μM) decreased Pgp expression in a concentration-dependent manner and was also found to have the same effect on MDR1 mRNA levels. The effect of curcumin on Pgp function was demonstrated by rhodamine 123 (Rh123) accumulation and efflux in Pgp-expressing KB-V1 cells. Curcumin increased Rh123 accumulation in a concentration-dependent manner (1-55μM) and inhibited the efflux of Rh123 from these cells, but did not affect the efflux of Rh123 from the wild-type drug-sensitive KB-3-1 cells. Treatment of drug-resistant KB-V1 cells with curcumin increased their sensitivity to vinblastine, which was consistent with an increased intracellular accumulation of Rh123. In addition, curcumin inhibited verapamil-stimulated ATPase activity and the photoaffinity labeling of Pgp with the prazosin analog [125I]iodoarylazidoprazosin in a concentration-dependent manner, demonstrating that curcumin interacts directly with the transporter. Thus, curcumin seems to be able to modulate the in vitro expression and function of Pgp in multidrug-resistant human KB-V1 cells. In summary, this study describes the duel modulation of MDR1 expression and Pgp function by the phytochemical curcumin, which may be an attractive new agent for the chemosensitization of cancer cells.

KW - ATP hydrolysis

KW - Chemosensitizers

KW - Curcumin

KW - KB-V1 cells

KW - Multidrug resistance

KW - P-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=0037103569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037103569&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(02)01224-8

DO - 10.1016/S0006-2952(02)01224-8

M3 - Article

C2 - 12167476

AN - SCOPUS:0037103569

VL - 64

SP - 573

EP - 582

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 4

ER -